Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Nektar Therapeutics - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
NKTR
Nasdaq
8731
http://www.nektar.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Nektar Therapeutics
Should Vanguard S&P Small-Cap 600 Growth ETF (VIOG) Be on Your Investing Radar?
- Apr 24th, 2018 7:48 am
Today’s Research Reports on Stocks to Watch: Nektar Therapeutics and Merck & Co.
- Apr 17th, 2018 6:20 am
Today’s Research Reports on Trending Tickers: Valeant Pharmaceuticals and Nektar Therapeutics
- Apr 16th, 2018 6:30 am
Nektar Therapeutics Presents New Preclinical Data for its Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2018
- Apr 15th, 2018 4:00 pm
These 3 Biotech Stocks Are Up More Than 500% Over the Last 3 Years
- Apr 13th, 2018 6:18 am
Nektar Starts Phase I/II Combo for Advanced Solid Tumors
- Apr 12th, 2018 8:37 am
Why CASI Pharmaceuticals Stock Rose Last Week
- Apr 11th, 2018 9:27 am
Stocks Selling Off Harder But These Small Caps Are Worth A Look
- Apr 11th, 2018 9:10 am
Nektar Announces Dosing of First Patient in Phase 1/2 Clinical Study to Evaluate Combination of TLR Agonist NKTR-262 with CD122-Biased Agonist NKTR-214 in Patients with Advanced Solid Tumors
- Apr 11th, 2018 6:00 am
Today’s Research Reports on Trending Tickers: Clovis Oncology and Nektar Therapeutics
- Apr 10th, 2018 6:30 am
See what the IHS Markit Score report has to say about Nektar Therapeutics.
- Apr 10th, 2018 6:07 am
Nektar Therapeutics: Top Gainer from S&P 500 in 1Q18
- Apr 9th, 2018 11:00 am
Here's Why Nektar Therapeutics Jumped 23% Higher in March
- Apr 8th, 2018 9:50 am
These S&P Stocks Jumped 50% in the 1st Quarter
- Apr 7th, 2018 9:48 am
How a Biotech Bummer Sent Nektar Therapeutics Stock South Today
- Apr 6th, 2018 1:59 pm
Benzinga's Top Analyst Calls From April 6, 2018
- Apr 6th, 2018 12:39 pm
Biotech Investors Should Consider The Four Horsemen
- Apr 6th, 2018 11:16 am
Nektar Therapeutics Announces Effective Date of Global Development & Commercialization Collaboration with Bristol-Myers Squibb
- Apr 3rd, 2018 3:30 pm
Analysts’ Recommendations for United Therapeutics in March 2018
- Apr 3rd, 2018 7:02 am
How Did United Therapeutics Perform in 4Q17 and Fiscal 2017?
- Apr 2nd, 2018 3:53 pm
Scroll